Humacyte, Inc. (HUMA) Misses Q1 EPS by 6c

Humacyte, Inc. (NASDAQ: HUMA) reported Q1 EPS of ($0.29), $0.06 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• BTIG Reiterates Buy Rating on Humacyte (HUMA)
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M